ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 31,074 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 2526 to 2550 of 8600 messages
Chat Pages: Latest  104  103  102  101  100  99  98  97  96  95  94  93  Older
DateSubjectAuthorDiscuss
23/2/2018
13:36
We all know for definite that news is coming, on more than one front.

If Carlsberg did N4P news ....

jakleeds
23/2/2018
13:24
13:16:59 31.0000 4,858 O 31.0000 32.0000 Sell 757,690 495,787
13:15:32 31.0000 4,858 O 31.0000 32.0000 Sell 757,690 490,929
13:14:24 31.0000 4,858 O 31.0000 32.0000 Sell 757,690 486,071
13:13:01 31.0000 4,858 O 31.0000 32.0000 Sell 757,690 481,213

Why would the MM`s be trying to suppress the SP?
They probably know that news is coming and don`t want to be left without stock.

hughwilson
23/2/2018
12:16
Urigem,
That is what I said before. 1286 cancer products in 2016. All would benefit from the improved delivery system that Nuvec offers, and the 1286 is just for cancer treatments.

hughwilson
23/2/2018
12:13
Today is N4P`s last day in Japan. I don`t envisage Nigel coming away empty-handed so we are looking probably at a number of news releases over the next few minutes/days/weeks.
hughwilson
23/2/2018
11:57
Just look at that one year chart...
parob
23/2/2018
11:53
if you want to buy any in quantity you either have to wait for some sellers or send to the broker?
jimmmy
23/2/2018
11:49
Have to go to market now for an even small amount.
Bring it on!

garbut
23/2/2018
11:48
new high today it would seem...DYOR
qs99
23/2/2018
11:09
Updown up down up.. A quick shot of reformulated Viagra would cure today's chart
urigem
23/2/2018
10:52
A bit of a shake and back up we go. Huge appetite for these shares. MC still only £28 million.
parob
23/2/2018
09:06
Turbulent times for the consolidation of this share. But no matter how much the mms knock, it continues to bounce back strong. Roll on 40p:)))
ch1rp
23/2/2018
08:36
I would like a nice Friday afternoon RNS- would make my weekend
urigem
23/2/2018
08:23
Very happy at these levels, I think if viagra plasma results come back as expected, NT will be tempted to go for Phase 111 alone. Once the Mkt grab a inspiration on the numbers may well be the best way to go.. Especially if some deals with Nuvec allow it to pay for it
urigem
23/2/2018
07:50
Given such a strong finish right into the close yesterday I suspect we will see a mad scramble for these today.

10 and a half minutes left ...

jakleeds
23/2/2018
07:28
And the first collaborative project is in the bag with AZ. Who's next!?
parob
23/2/2018
07:15
FROM N4P Website

N4 Pharma is investigating the use of its Nuvec technology in the field of cancer vaccines. Global revenues for the cancer vaccines market are forecast by Global Business Intelligence in their November report “Global Cancer Vaccines Market to 2022” to grow at a CAGR of 16.9 per cent., from $2.5 billion in 2015 to $7.5 billion in 2022. The cancer vaccine pipeline is large with 1,286 products in development in November 2016. This represents a significant market opportunity for Nuvec. The N4 Pharma Directors believe that once the ‘proof of concept’ data pack has been developed for Nuvec, which is expected to be completed within the next 12 months, business development will commence to establish collaborative research projects with potential partners.

urigem
22/2/2018
21:19
Hugh Wilson@HughWilson232Replying to @AIM_Chaos#n4pMyles, can I just question your sildenafil results date of June when the company have said by the end of April.Forest@ianforestdreamsThat's my understanding Hugh. Human trials Q1, results end of April. ATBAIM Chaos@AIM_ChaosHope so guys. Just being conservative again. Irrelevant really as think news flow from both Nuvec and Silden will be more regular from now. In fact, reason I have not yet published an updated valuation for #N4P - think we'll get comprehensive updates on both in next few weeks.
parob
22/2/2018
20:00
Thats not a service i personally will offer, any volunteers for the “ dont be out of this share at the weekend ” service?

Hee hee hee!!!

escapetohome
22/2/2018
19:51
its about time someone said 'not one to be out of over the weekend'
paddyfool
22/2/2018
19:16
escapetohome22 Feb '18 - 08:18 - 81 of 81 Edit
0 0 0
BLUE FINISH , strong recovery as per usual!

Oops! my blue finish advice service was on the other thread this am . Sorry folks
,!!

escapetohome
22/2/2018
18:49
Aim_Chaos on twitter just now:#N4P's Nuvec platform already attracting the likes of AstraZeneca - amazing. Many more tier 1 pharmas will partner with N4 for Nuvec in future, IMO. A genuine industry gamechanger.Sildenafil results due June. Also a potential gamechanger for ED market.Phenomenal upside here.
parob
22/2/2018
18:34
tp6,
It does look likely that we will get news on JV`s or collaborations from Japan in the coming days/weeks.

hughwilson
22/2/2018
18:21
Japan, one of the world's richest business markets, once had a reputation as a difficult business environment for some foreign companies. So why have many of the world's best-known life science companies successfully expanded into Japan in recent years?From Finland to Israel, from Australia to Portugal, from the U.S. to the U.K, small and large corporations have realized that Japan's aging society represents opportunities in health sciences, while the country has loosened several key policies, regulations, and laws to open the door for foreign investment. 
tp6
22/2/2018
18:21
Parob,
N4`s final day in Japan is the 24th. After that we have 3 months of the British Embassy facilitating any negotiations.

hughwilson
22/2/2018
18:20
https://hbr.org/sponsored/2018/02/how-japan-is-creating-new-opportunities-for-life-sciences-companies
tp6
Chat Pages: Latest  104  103  102  101  100  99  98  97  96  95  94  93  Older

Your Recent History

Delayed Upgrade Clock